Drugs & TargetsFree FDA approves Retevmo, first therapy for lung and thyroid cancers with RET gene alterations May 15, 2020Vol.46 No.20
Drugs & TargetsFree FDA approves Lynparza + bevacizumab as maintenance treatment for ovarian, fallopian tube, or primary peritoneal cancers May 15, 2020Vol.46 No.20
FreeIn Brief DFCI and Silverberry Genomix form population health initiative for research and education May 15, 2020Vol.46 No.20
FreeIn Brief Paczesny, Mehrotra named co-leaders of cancer immunology at Hollings Cancer Center May 15, 2020Vol.46 No.20
COVID-19 UpdatesFree Heartland NCORP sites implement drive-through laboratory service May 15, 2020Vol.46 No.20
COVID-19 UpdatesFree Roswell Park to assess immunotherapy combination in cancer patients with COVID-19 May 15, 2020Vol.46 No.20
COVID-19 UpdatesFree MSK Kids study: Children with cancer are not at a higher risk for COVID-19 infection or morbidity May 15, 2020Vol.46 No.20
